Eton Pharmaceuticals (ETON) Change in Inventory (2020 - 2025)
Eton Pharmaceuticals (ETON) reported Change in Inventory of $581000.0 for Q4 2025, down 28.45% on a YoY basis from $812000.0 in Q4 2024, and up 110.35% sequentially from -$5.6 million in Q3 2025.
Eton Pharmaceuticals (ETON) Change in Inventory (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 6 years of Change in Inventory data on file, last reported at $581000.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory fell 28.45% year-over-year to $581000.0; the trailing twelve-month figure through Dec 2025 stood at $5.9 million (up 219.52% YoY), and the FY2025 full-year result was $5.9 million, up 219.52% from the prior year.
- Change in Inventory advanced to $581000.0 in Q4 2025, from -$5.6 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $11.4 million in Q2 2025 to a low of -$5.6 million in Q3 2025.
- A 5-year average of $467388.9 and a median of $48500.0 in 2022 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 4650.8% in 2025, while the deepest fall reached 4218.46% in 2025.
- Tracing ETON's Change in Inventory over 5 years: stood at $216000.0 in 2021, then slumped by 64.81% to $76000.0 in 2022, then sank by 264.47% to -$125000.0 in 2023, then surged by 749.6% to $812000.0 in 2024, then fell by 28.45% to $581000.0 in 2025.
- Business Quant data shows ETON's Change in Inventory at $581000.0 in Q4 2025, -$5.6 million in Q3 2025, and $11.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 40.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Eton Pharmaceuticals | 1.14 Bn | 1.11 Bn | 13.10 Mn | 581,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 581,000.00 |
| Dec 31, 2025 | 581,000.00 |
| Sep 30, 2025 | -5.61 Mn |
| Sep 30, 2025 | -5.61 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Jun 30, 2025 | 11.38 Mn |
| Mar 31, 2025 | -468,000.00 |
| Mar 31, 2025 | -468,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Dec 31, 2024 | 812,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Sep 30, 2024 | -130,000.00 |
| Jun 30, 2024 | -250,000.00 |
| Jun 30, 2024 | -250,000.00 |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | -125,000.00 |
| Dec 31, 2023 | -125,000.00 |
| Sep 30, 2023 | 235,000.00 |
| Sep 30, 2023 | 235,000.00 |